Fig. 10From: Crosstalk of disulfidptosis-related subtypes identifying a prognostic signature to improve prognosis and immunotherapy responses of clear cell renal cell carcinoma patientsPrediction of sensitivity to chemotherapeutic drugs between the low- and high-risk groups. *P < 0.05, **P < 0.01, ***P < 0.001, ns: no significanceBack to article page